AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenberg, J. A
Right arrow Articles by Kassotis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenberg, J. A
Right arrow Articles by Kassotis, J.
Agricola
Right arrow Articles by Greenberg, J. A
Right arrow Articles by Kassotis, J.
American Journal of Clinical Nutrition, Vol. 85, No. 2, 392-398, February 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis1,2

James A Greenberg, Christopher C Dunbar, Roseanne Schnoll, Rodamanthos Kokolis, Spyro Kokolis and John Kassotis

1 From Brooklyn College of the City University of New York, New York, NY (JAG, CCD, and RS), and the Department of Cardiology, State University of New York Health Science Center at Brooklyn, Brooklyn, NY (RK, SK, and JK)

Background:Motivated by the possibility that caffeine could ameliorate the effect of postprandial hypotension on a high risk of coronary events and mortality in aging, we hypothesized that caffeinated beverage consumption decreases the risk of cardiovascular disease (CVD) mortality in the elderly.

Objective:The objective of the study was to use prospective cohort study data to test whether the consumption of caffeinated beverages exhibits this protective effect.

Design:Cox regression analyses were conducted for 426 CVD deaths that occurred during an 8.8-y follow-up in the prospective first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. The analysis involved 6594 participants aged 32–86 y with no history of CVD at baseline.

Results:Participants aged ≥65 y with higher caffeinated beverage intake exhibited lower relative risk of CVD and heart disease mortality than did participants with lower caffeinated beverage intake. It was a dose-response protective effect: the relative risk (95% CI) for heart disease mortality was 1.00 (referent), 0.77 (0.54, 1.10), 0.68 (0.49, 0.94), and 0.47 (0.32, 0.69) for <0.5, 0.5–2, 2–4, and ≥4 servings/d, respectively (P for trend = 0.003). A similar protective effect was found for caffeine intake in mg/d. The protective effective was found only in participants who were not severely hypertensive. No significant protective effect was found in participants aged <65 y or in cerebrovascular disease mortality for those aged ≥65 y.

Conclusion:Habitual intake of caffeinated beverages provided protection against the risk of heart disease mortality among elderly participants in this prospective epidemiologic analysis.

Key Words: Aging • beverages • caffeine • cardiovascular disease • coffee • heart disease • mortality risk




This article has been cited by other articles:


Home page
Clin. Chem.Home page
R. M. van Dam
Coffee Consumption and Coronary Heart Disease: Paradoxical Effects on Biological Risk Factors versus Disease Incidence
Clin. Chem., September 1, 2008; 54(9): 1418 - 1420.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
E. Lopez-Garcia, R. M. van Dam, T. Y. Li, F. Rodriguez-Artalejo, and F. B. Hu
The Relationship of Coffee Consumption with Mortality
Ann Intern Med, June 17, 2008; 148(12): 904 - 914.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition